United States · Series A startup

Who invested in AvengeBio

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$45Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $45MJan 2022
Investors
2
See who backed them

The rounds

  1. Jan 2022
    Series A$45M

    Source recorded

Everyone who backed them

Perceptive AdvisorsAsset manager1round
Longitude CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about AvengeBio

Who invested in AvengeBio?

AvengeBio's investors include Perceptive Advisors and Longitude Capital.

How much has AvengeBio raised?

AvengeBio has raised $45M across 1 round since 2022.

When did AvengeBio last raise?

AvengeBio's most recent round was a Series A of $45M in Jan 2022.

What was AvengeBio's biggest round?

Its most recent round, $45M in Jan 2022, is also its largest on record.

Who backed AvengeBio first?

AvengeBio's first round on record, in Jan 2022, was backed by Perceptive Advisors and Longitude Capital.

What stage is AvengeBio at?

AvengeBio's latest named round is a Series A, in Jan 2022.

Where is AvengeBio based?

AvengeBio is based in the United States.

Companies like AvengeBio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.